Your trusted destination for CME, CPD & Medical Education across the Middle East.
The conference focuses on diabetic neuropathy, neuropathic pain, diabetes-related neurological complications, and pain management. Topics may include peripheral and autonomic neuropathy, neuropathic pain mechanisms, diagnostic testing, nerve-function assessment, diabetic foot complications, pharmacological therapies, non-pharmacological pain management, rehabilitation, lifestyle interventions, patient education, and emerging treatments.
The International Conference on Diabetic Neuropathy and Pain Management (ICDNP-26) brings together neurologists, diabetologists, endocrinologists, pain specialists, physicians, researchers, nurses, and allied healthcare professionals to explore advances in diabetic neuropathy and related pain conditions. The conference focuses on the mechanisms, diagnosis, prevention, and clinical management of peripheral and other forms of diabetic neuropathy. It provides a platform for sharing research findings, clinical experiences, diagnostic approaches, and emerging therapeutic strategies for neuropathic pain and diabetes-related nerve complications. Key discussions may address peripheral neuropathy, neuropathic pain, autonomic neuropathy, diabetic foot complications, nerve-function assessment, and risk-factor management. The program also explores pharmacological and non-pharmacological pain management, rehabilitation, lifestyle interventions, and emerging therapies aimed at improving functional outcomes and quality of life. Participants can exchange knowledge on multidisciplinary approaches to early detection, symptom management, and prevention of complications associated with diabetic neuropathy. ICDNP-26 aims to promote collaboration and advance evidence-based approaches to the comprehensive management of diabetic neuropathy and pain.
Understanding the mechanisms through which diabetes damages peripheral and autonomic nerves.
Recognition of common manifestations, progression, and functional consequences of peripheral nerve damage.
Assessment and management of complications resulting from dysfunction of the autonomic nervous system.
Identification of early sensory, motor, and pain-related symptoms to facilitate timely intervention.
Clinical screening techniques used to identify loss of sensation and peripheral nerve dysfunction.
Assessment of diabetic feet and identification of patients at increased risk of ulcers and other complications.
Evaluation of neuropathic pain characteristics and differentiation from other causes of pain.
Use and appropriate selection of medications such as gabapentinoids, SNRIs, tricyclic antidepressants, and sodium-channel blockers.
Combining pharmacological and non-pharmacological approaches for patients with difficult-to-control neuropathic pain.
Complementary approaches that may help reduce pain and improve physical function and quality of life.
Exploring the role of blood-glucose management in preventing or slowing progression of diabetic neuropathy.
Management of metabolic and cardiovascular risk factors that may influence neuropathy progression and overall health.
Strategies for preventing and treating diabetic foot ulcers and reducing complications.
Early identification and multidisciplinary management of patients at increased risk of amputation.
Addressing sleep disturbance, psychological effects, reduced mobility, and quality-of-life challenges associated with neuropathy.
Rehabilitation strategies to maintain mobility, function, independence, and quality of life.
Understanding the interaction between chronic neuropathic pain, psychological well-being, and patient functioning.
Review of developing therapeutic approaches and emerging research in diabetic neuropathy and pain management.
Secure your seat and earn full credit eligibility with encrypted checkout.
Secure payment processing & PCI-aligned flow